Yufang Zuo

790 total citations
28 papers, 611 citations indexed

About

Yufang Zuo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yufang Zuo has authored 28 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yufang Zuo's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yufang Zuo is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yufang Zuo collaborates with scholars based in China and United States. Yufang Zuo's co-authors include Wenlin Huang, Jiangxue Wu, Ranyi Liu, Xiangqi Meng, Xiaofang Ying, Hui Wang, Zhizhong Pan, Zumin Xu, Tiebang Kang and Zhonghua Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Yufang Zuo

26 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufang Zuo China 13 454 330 137 53 38 28 611
Cecil Han United States 8 543 1.2× 297 0.9× 133 1.0× 47 0.9× 38 1.0× 11 650
Rachel J. Suetani Australia 9 434 1.0× 313 0.9× 185 1.4× 28 0.5× 37 1.0× 12 617
Aleksandra Balwierz Germany 7 517 1.1× 422 1.3× 127 0.9× 52 1.0× 35 0.9× 10 674
Hossein Tabatabaeian Iran 17 544 1.2× 354 1.1× 122 0.9× 56 1.1× 50 1.3× 40 702
Hanshao Liu Japan 9 617 1.4× 380 1.2× 190 1.4× 52 1.0× 44 1.2× 13 777
Ruifen Dong China 15 419 0.9× 360 1.1× 111 0.8× 65 1.2× 57 1.5× 22 685

Countries citing papers authored by Yufang Zuo

Since Specialization
Citations

This map shows the geographic impact of Yufang Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufang Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufang Zuo more than expected).

Fields of papers citing papers by Yufang Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufang Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufang Zuo. The network helps show where Yufang Zuo may publish in the future.

Co-authorship network of co-authors of Yufang Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Yufang Zuo. A scholar is included among the top collaborators of Yufang Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufang Zuo. Yufang Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zuo, Yufang, Shilei Yang, Xufeng Tao, et al.. (2025). Contribution and expression of renal drug transporters in renal cell carcinoma. Frontiers in Pharmacology. 15. 1466877–1466877. 3 indexed citations
3.
Liu, Xiulan, Yanyan Xu, Brant G. Wang, et al.. (2023). Bronchiolar adenoma/ciliated muconodular papillary tumour: advancing clinical, pathological, and imaging insights for future perspectives. Clinical Radiology. 79(2). 85–93. 1 indexed citations
4.
5.
Zuo, Yufang, et al.. (2023). Imaging evaluation of para-aortic lymph nodes in cervical cancer. Acta Radiologica. 64(9). 2611–2617. 3 indexed citations
6.
Yang, Jing, Xiaowen Chen, Xiaofang Li, et al.. (2023). Case Report: Clinical application of immunotherapy-based combination regimen in primary osteosarcoma of the uterus. Frontiers in Oncology. 13. 1198765–1198765.
7.
Xu, Zumin, et al.. (2021). Application of an Autophagy-Related Gene Prognostic Risk Model Based on TCGA Database in Cervical Cancer. Frontiers in Genetics. 11. 616998–616998. 18 indexed citations
8.
Chen, Guoqiang, Xiaqing Yu, Min Zhang, et al.. (2019). Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells. Cytogenetic and Genome Research. 158(4). 205–212. 6 indexed citations
9.
Yang, Qingmei, Yuan Liu, Yan Peng, et al.. (2018). MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7. Technology in Cancer Research & Treatment. 17. 1077077641–1077077641. 31 indexed citations
10.
11.
Zuo, Yufang, Dongyan Yang, Mei Xiang, et al.. (2017). Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc. Molecular Medicine Reports. 17(3). 3497–3502. 20 indexed citations
12.
Xu, Zumin, Yufang Zuo, Jin Wang, et al.. (2015). Overexpression of the regulator of G-protein signaling 5 reduces the survival rate and enhances the radiation response of human lung cancer cells. Oncology Reports. 33(6). 2899–2907. 15 indexed citations
13.
Xu, Zhonghua, Yang Dong, Fang Peng, et al.. (2015). Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice. Cancer Gene Therapy. 22(4). 181–187. 8 indexed citations
14.
Zuo, Yufang, et al.. (2014). A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma. Oncology Reports. 32(6). 2564–2570. 4 indexed citations
15.
Chen, Xinggui, Ying Yu, Zhennan Wang, et al.. (2014). Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway. Oncology Reports. 32(6). 2596–2604. 28 indexed citations
16.
Meng, Xiangqi, Jiangxue Wu, Changchuan Pan, et al.. (2013). Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD. Gastroenterology. 145(2). 426–436.e6. 103 indexed citations
17.
Ying, Xiaofang, Jiangxue Wu, Xiangqi Meng, et al.. (2013). AC133 expression associated with poor prognosis in stage II colorectal cancer. Medical Oncology. 30(1). 356–356. 13 indexed citations
18.
Peng, Fang, Zumin Xu, Jin Wang, et al.. (2012). Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models. PLoS ONE. 7(4). e34646–e34646. 56 indexed citations
19.
20.
Li, Tan, Hongyun Jia, Ranyi Liu, et al.. (2008). Inhibition of NF-κB in fusogenic membrane glycoprotein causing HL-60 cell death: Implications for acute myeloid leukemia. Cancer Letters. 273(1). 114–121. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cecil Han Breakdown of academic impact, for papers by Rachel J. Suetani Breakdown of academic impact, for papers by Aleksandra Balwierz Breakdown of academic impact, for papers by Hossein Tabatabaeian Breakdown of academic impact, for papers by Hanshao Liu Breakdown of academic impact, for papers by Ruifen Dong
Rankless by CCL
2026